title: HDAC1 bound to the Cyp1a1 promoter blocks histone acetylation associated with Ah receptor-mediated trans-activation.
abstract: Metabolic bioactivation of polycyclic aromatic hydrocarbons, such as the environmental procarcinogen benzo[a]pyrene, is catalyzed by a cytochrome P450 monooxygenase encoded by the substrate-inducible Cyp1a1 gene. Cyp1a1 induction requires trans-activation by the heterodimeric transcriptional complex formed by the liganded Ah receptor (AHR) and its partner, ARNT. Previously, we showed that constitutively bound HDAC1 dissociates from Cyp1a1 promoter chromatin after ligand-mediated induction, concomitantly with the recruitment of AHR/ARNT complexes and p300. Here, we investigated the hypothesis that HDAC1 binding maintains the Cyp1a1 gene in a silenced state in uninduced cells. We find that Cyp1a1 induction by the AHR/ARNT is associated with modification of specific chromatin marks, including hyperacetylation of histone H3K14 and H4K16, trimethylation of histone H3K4, and phosphorylation of H3S10. HDAC1 and DNMT1 form complexes on the Cyp1a1 promoter of uninduced cells but HDAC1 inhibition alone is not sufficient to induce Cyp1a1 expression, although it allows for the hyperacetylation of H3K14 and H4K16 to levels similar to those found in B[a]P-induced cells. These results show that by blocking the modification of histone marks, HDAC1 plays a central role in Cyp1a1 expression and that its removal is a necessary but not sufficient condition for Cyp1a1 induction, underscoring the requirement for a concerted series of chromatin-remodeling events to complete the initial steps of gene trans-activation by the Ah receptor.
authors: Center for Environmental Genetics and Department of Environmental Health, University of Cincinnati Medical Center, P.O. Box 670056, Cincinnati, Ohio 45267-0056, USA.
authors: Michael
authors: M
authors: Schnekenburger
authors: Li
authors: L
authors: Peng
authors: Alvaro
authors: A
authors: Puga
mesh_terms: D000107:Acetylation; D000818:Animals; D001564:Benzo(a)pyrene / Q000378:metabolism; D002352:Carrier Proteins / Q000235:genetics / Q000378:metabolism; D002384:Catalysis; D045744:Cell Line, Tumor; D042002:Chromatin Assembly and Disassembly / Q000502:physiology; D019363:Cytochrome P-450 CYP1A1 / Q000096:biosynthesis*; D000076123:DNA (Cytosine-5-)-Methyltransferase 1; D004248:DNA (Cytosine-5-)-Methyltransferases / Q000378:metabolism; D004790:Enzyme Induction / Q000502:physiology; D004794:Enzyme Repression / Q000502:physiology; D005326:Fetal Proteins / Q000235:genetics / Q000378:metabolism; D056284:Histone Deacetylase 1; D006655:Histone Deacetylases / Q000378:metabolism*; D006657:Histones / Q000378:metabolism*; D008745:Methylation; D051379:Mice; D008869:Microtubule-Associated Proteins; D010766:Phosphorylation; D011401:Promoter Regions, Genetic / Q000502:physiology*; D011485:Protein Binding / Q000502:physiology; D011499:Protein Processing, Post-Translational / Q000502:physiology; D018336:Receptors, Aryl Hydrocarbon / Q000378:metabolism*; D015533:Transcriptional Activation / Q000502:physiology*; D050880:p300-CBP Transcription Factors
chemical_list: D002352:Carrier Proteins; D005326:Fetal Proteins; D006657:Histones; D008869:Microtubule-Associated Proteins; D018336:Receptors, Aryl Hydrocarbon; C418485:TACC3 protein, mouse; D001564:Benzo(a)pyrene; D019363:Cytochrome P-450 CYP1A1; D000076123:DNA (Cytosine-5-)-Methyltransferase 1; D004248:DNA (Cytosine-5-)-Methyltransferases; C000619381:Dnmt1 protein, mouse; D050880:p300-CBP Transcription Factors; C484389:Hdac1 protein, mouse; D056284:Histone Deacetylase 1; D006655:Histone Deacetylases
references: Mol Cell Biol. 2001 Apr;21(7):2594-607
references: 11259606
references: Nature. 2005 Aug 25;436(7054):1103-6
references: 16121170
references: Carcinogenesis. 2001 Jul;22(7):1077-86
references: 11408352
references: Mol Cell Biol. 2002 Mar;22(6):1844-57
references: 11865062
references: J Biol Chem. 2002 Apr 5;277(14):11821-7
references: 11805098
references: Mol Cell Biol. 2002 Jun;22(12):4319-33
references: 12024042
references: Methods. 2002 Jan;26(1):48-56
references: 12054904
references: Mol Cell Biol. 2003 Nov;23(21):7920-5
references: 14560034
references: J Biol Chem. 2003 Nov 7;278(45):44041-8
references: 12917420
references: N Engl J Med. 2003 Nov 20;349(21):2042-54
references: 14627790
references: Cancer Sci. 2004 Jan;95(1):1-6
references: 14720319
references: J Biol Chem. 2004 Feb 6;279(6):4110-9
references: 14625279
references: J Cell Biochem. 2004 Sep 1;93(1):57-67
references: 15352162
references: Annu Rev Pharmacol Toxicol. 1982;22:517-54
references: 6282188
references: Cancer Res. 1982 Dec;42(12):4875-917
references: 6814745
references: Mol Cell Biol. 1989 Jun;9(6):2378-86
references: 2548080
references: Cell. 2005 Sep 9;122(5):654-8
references: 16143099
references: Eur J Cancer. 2005 Nov;41(16):2381-402
references: 16226460
references: Science. 2006 Feb 10;311(5762):844-7
references: 16469925
references: Cancer Res. 2006 Apr 1;66(7):3541-9
references: 16585178
references: Cell. 2006 Apr 21;125(2):315-26
references: 16630819
references: J Biol Chem. 2006 May 26;281(21):14654-62
references: 16567799
references: J Immunol. 2006 Jul 15;177(2):1282-8
references: 16818788
references: Cancer Res. 2006 Aug 1;66(15):7420-8
references: 16885337
references: Cancer Biol Ther. 2007 Jan;6(1):64-9
references: 17172825
references: Genes Dev. 2000 Jan 1;14(1):45-54
references: 10640275
references: J Biol Chem. 2000 Mar 24;275(12):8432-8
references: 10722677
references: Nat Genet. 2000 Jul;25(3):338-42
references: 10888886
references: Genes Dev. 2000 Jul 15;14(14):1810-23
references: 10898795
references: Cell. 2000 Oct 13;103(2):263-71
references: 11057899
references: J Biol Chem. 1989 Oct 25;264(30):17754-8
references: 2553691
references: Crit Rev Toxicol. 1989;20(3):153-74
references: 2558673
references: Mol Cell Biol. 1990 Apr;10(4):1470-5
references: 2320004
references: Mol Cell Biol. 1990 Oct;10(10):5098-105
references: 2398886
references: Mol Cell Biol. 1992 Apr;12(4):1856-63
references: 1312672
references: J Biol Chem. 1992 Apr 5;267(10):6874-8
references: 1313025
references: Proc Natl Acad Sci U S A. 1992 Dec 1;89(23):11622-6
references: 1454854
references: Annu Rev Pharmacol Toxicol. 1995;35:307-40
references: 7598497
references: Mol Cell Biol. 1996 Jan;16(1):430-6
references: 8524325
references: Biochem Pharmacol. 1997 Apr 4;53(7):951-7
references: 9174108
references: J Biochem. 1997 Oct;122(4):703-10
references: 9399571
references: J Biol Chem. 1998 Jan 30;273(5):2895-904
references: 9446600
references: Arch Biochem Biophys. 1999 Jul 15;367(2):250-7
references: 10395741
references: J Biol Chem. 1999 Aug 6;274(32):22155-64
references: 10428779
references: J Biol Chem. 1999 Oct 1;274(40):28708-15
references: 10497241
references: Annu Rev Genet. 2004;38:413-43
references: 15568982
references: J Biol Chem. 2005 Jan 28;280(4):2446-54
references: 15537652
references: Annu Rev Biochem. 2005;74:481-514
references: 15952895
references: J Cell Biol. 2001 Feb 19;152(4):669-82
references: 11266459